Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Sector news Pharmaceuticals - NEC
01:32pDJELI LILLY AND : Sees Modest Revenue Growth in 2018
10:09aDJPLANT IMPACT : Needs Extra GBP7 Million Funding by April, Hands up 'For Sale' Si..
12/12 Sanofi investors hungry for drug progress and deal news
12/12DJMERCK : Appoints Allan Gabor as Managing Director in China
12/12DJGLAXOSMITHKLINE : Encouraged By Blood-Cancer Drug Study
12/12DJGLAXOSMITHKLINE : Nucala gets FDA Approval for EGPA
12/12 Monsanto offers cash to U.S. farmers who use controversial chemical
12/11 ASTRAZENECA : GSK's new pharma head on lookout for cancer deals to boost pipelin..
12/11 Merck raises stakes in lung cancer as rivals close in
12/11DJROCHE : Reports Positive Results From IMmotion151 Kidney Cancer Trial
12/11 ROCHE : Tecentriq cocktail slows kidney cancer progression
12/08 EU regulators to warn Bayer about Monsanto bid
12/08 ALEXION PHARMACEUTICALS : Elliott Management seeks changes at Alexion - NYT
12/08 Wall Street closes higher after payrolls report
12/08 TEVA CONSIDERING CUTTING UP TO 10,00 : Bloomberg
12/08 TEVA CONSIDERING CUTTING UP TO 10,00 : Bloomberg
12/08DJSHIRE : Names John Miller as Interim CFO From Jan. 1
12/08DJTEVA PHARMACEUTICAL INDUSTRIES : May Cut Up to 10,000 Jobs -Bloomberg
12/08DJSHIRE PLC SHIRE PLC : Directorate Change
12/08DJROCHE : Novartis's Italian Heads Risk Trial for Alleged Market Rigging -Reuters
12/08 ROCHE, NOVARTIS' ITALIAN HEADS RISK : sources
12/07 TSX gains in broad rally led by financials, energy stocks
12/07 Comeback in banks, tech lifts euro zone stocks as Steinhoff collapses
12/07 Roche drug cocktail doubles chance of holding lung cancer at bay
12/07 Whitbread jumps after hedge fund Sachem Head declares stake
12/07 Companies prepare for disorderly Brexit as talks stall
12/07DJROCHE : Posts Positive Phase 3 Interim Results in Hemophilia Study
12/07DJROCHE : Reports Positive Results From IMpower150 Lung Cancer Trial
12/07DJROCHE : Immunotherapy Drug Tecentriq Extended Patients' Lives in Study
12/06 Roche to seize leap-frog opportunity in lung cancer
12/06DJROCHE : Avastin Granted Full Approval by FDA to Treat Glioblastoma
12/06 GSK, other drugmakers bet on post-Brexit UK science
12/06DJBAYER : Johnson & Johnson Ordered to Pay $27.8 Million in Xarelto Lawsuit -Reute..
12/06DJCREDIT MARKETS : Tax Bill Benefits Corporate Bonds -- WSJ
12/06 Australian watchdog takes GlaxoSmithKline, Novartis units to court
12/05 BAYER : Jury orders Bayer, Johnson & Johnson to pay $28 million in Xarelto lawsu..
12/05 MERCK : Nestle to buy vitamin maker Atrium Innovations for $2.3 billion
12/05DJNOVO NORDISK A/S : U.S. FDA Approves Novo Nordisk's Diabetes Treatment
12/05 Paul Singer's Elliott takes stake in takeover target Uniper
12/05DJRoche's Breast Cancer Drug Herceptin Faces Biosimilar Competition -Cinco Dias
12/04DJASTRAZENECA : Says Hard Brexit Could Mean $35.5 Million in Extra Annual Costs
12/04 IDORSIA : to get $230 million from J&J in latest hypertension deal
12/04 FOUNDATION MEDICINE : Roche's Foundation Medicine wins FDA blessing for new canc..
12/01 Tech firms tell patent court to ignore Allergan deal with tribe
12/01 Nestle, Stada prepare rival bids for Germany's Merck consumer health - source..
12/01 FTSE falls in broad risk-off move as Trump worries resurface
12/01 European stocks sink on Flynn guilty plea after choppy session
12/01 European stocks sink on Flynn guilty plea after choppy session
12/01DJSHIRE PLC SHIRE PLC : Total Voting Rights
12/01DJSHIRE : Appoints New Chief Scientific Officer, Chief Medical Officer
Financials (€)
Sales 2017 35 791 M
EBIT 2017 9 201 M
Net income 2017 8 158 M
Debt 2017 4 979 M
Yield 2017 4,03%
P/E ratio 2017 11,75
P/E ratio 2018 16,29
EV / Sales 2017 2,79x
EV / Sales 2018 2,74x
Capitalization 94 773 M
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
SANOFI-4.32%109 438
JOHNSON & JOHNSON21.53%379 175
NOVARTIS12.01%218 773
PFIZER10.04%215 837
ROCHE HOLDING LTD.3.40%209 423
MERCK AND COMPANY-6.96%153 659
AMGEN19.97%128 363
BRISTOL-MYERS SQUIBB COMPANY6.81%103 145
NOVO NORDISK A/S29.49%102 404
BAYER5.62%102 387
ABBOTT LABORATORIES42.38%95 629
ELI LILLY AND COMPANY17.54%95 432
GLAXOSMITHKLINE-17.57%85 531
CELGENE CORPORATION-8.35%85 030
ASTRAZENECA9.90%82 666
ALLERGAN PLC-20.10%57 457
SHIRE-20.69%45 243
TAKEDA PHARMACEUTICAL CO LTD26.68%43 072
JIANGSU HENGRUI MEDICINE CO LTD43.69%29 538
CHUGAI PHARMACEUTICAL CO LTD75.86%29 246
ASTELLAS PHARMA INC-11.32%26 179